Teng Mingxing, Young Damian W, Tan Zhi
Department of Pathology & Immunology, and Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas 77030, United States.
J Med Chem. 2022 Nov 10;65(21):14289-14304. doi: 10.1021/acs.jmedchem.2c01291. Epub 2022 Oct 20.
A range of enzymes drive human physiology, and their activities are tightly regulated through numerous signaling pathways. Depending on the context, these pathways may activate or inhibit an enzyme as a way to ensure proper execution of cellular functions. From a drug discovery and development perspective, pharmacological inhibition of enzymes has been a focus of interest, as many diseases are associated with the upregulation of enzyme function. On the other hand, however, pharmacological activation of enzymes such as kinases and phosphatases has been of increasing interest. In this review, we discuss seven case studies that highlight pharmacological activation strategy, describe the binding modes and pharmacology of the activators, and comment on how this on-demand activation strategy complements the commonly pursued inhibition strategy, thus jointly enabling bidirectional modulation of specific target of interest. Going forward, we expect activators to play important roles as chemical probes and drug leads.
一系列酶驱动着人体生理机能,其活性通过众多信号通路受到严格调控。根据具体情况,这些信号通路可能激活或抑制一种酶,以此确保细胞功能的正常执行。从药物发现与开发的角度来看,酶的药理学抑制一直是研究热点,因为许多疾病都与酶功能上调有关。然而,另一方面,诸如激酶和磷酸酶等酶的药理学激活也越来越受到关注。在本综述中,我们讨论了七个突出药理学激活策略的案例研究,描述了激活剂的结合模式和药理学特性,并评论了这种按需激活策略如何补充通常采用的抑制策略,从而共同实现对特定目标靶点的双向调控。展望未来,我们预计激活剂将作为化学探针和药物先导发挥重要作用。